Citadel Advisors’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-210,122
| Closed | -$238K | – | 7245 |
|
|
2022
Q2 | $238K | Buy |
210,122
+189,524
| +920% | +$215K | ﹤0.01% | 4844 |
|
|
2022
Q1 | $105K | Buy |
20,598
+18,733
| +1,004% | +$95.5K | ﹤0.01% | 5632 |
|
|
2021
Q4 | $11K | Sell |
1,865
-7,161
| -79% | -$42.2K | ﹤0.01% | 6357 |
|
|
2021
Q3 | $100K | Sell |
9,026
-2,482
| -22% | -$27.5K | ﹤0.01% | 5880 |
|
|
2021
Q2 | $195K | Buy |
11,508
+9,458
| +461% | +$160K | ﹤0.01% | 5598 |
|
|
2021
Q1 | $54K | Buy |
+2,050
| New | +$54K | ﹤0.01% | 6083 |
|
|
2020
Q4 | – | Sell |
-3,026
| Closed | -$107K | – | 5821 |
|
|
2020
Q3 | $107K | Buy |
3,026
+512
| +20% | +$18.1K | ﹤0.01% | 4241 |
|
|
2020
Q2 | $107K | Buy |
2,514
+1,084
| +76% | +$46.1K | ﹤0.01% | 4227 |
|
|
2020
Q1 | $114K | Buy |
+1,430
| New | +$114K | ﹤0.01% | 4315 |
|
|
2017
Q3 | – | Sell |
-363
| Closed | -$18K | – | 4277 |
|
|
2017
Q2 | $18K | Buy |
363
+206
| +131% | +$10.2K | ﹤0.01% | 3532 |
|
|
2017
Q1 | $23K | Buy |
+157
| New | +$23K | ﹤0.01% | 3506 |
|
|
2016
Q4 | – | Sell |
-164
| Closed | -$17K | – | 4279 |
|
|
2016
Q3 | $17K | Buy |
+164
| New | +$17K | ﹤0.01% | 3469 |
|